v3.22.1
CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Previously Reported [Member]
Common Stock [Member]
Revision of Prior Period, Adjustment [Member]
Common Stock [Member]
Additional Paid-in Capital
Previously Reported [Member]
Additional Paid-in Capital
Revision of Prior Period, Adjustment [Member]
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Previously Reported [Member]
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive (Loss)
Previously Reported [Member]
Accumulated Other Comprehensive (Loss)
Treasury Stock
Previously Reported [Member]
Treasury Stock
Revision of Prior Period, Adjustment [Member]
Previously Reported [Member]
Total
Beginning Balance at Dec. 29, 2018 $ 5 $ 4 $ 9 $ 553,843 $ (4,324) $ 549,519 $ (61,871) $ (61,871) $ (37,590) $ (37,590) $ (4,320) $ 4,320 $ 450,067 $ 450,067
Beginning Balance (in shares) at Dec. 29, 2018 547,129 88,852,377 89,399,506               (4,740,000) 4,740,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net Loss               (85,479)           (85,479)
Stock-based compensation           2,981               2,981
Proceeds from exercise of stock options           100               100
Proceeds from exercise of stock options (in shares)     16,483                      
Proceeds from sale of stock           750               750
Proceeds from sale of stock (in shares)     88,299                      
Stock Issued During Period, Value, Other           750               750
Vesting of restricted shares     45,327                      
Change in cumulative foreign currency translation adjustment                   5,550       5,550
Ending Balance at Dec. 28, 2019     $ 9     553,350   (147,350)   (32,040)       373,969
Ending Balance (in shares) at Dec. 28, 2019     89,549,615                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net Loss               (24,499)           (24,499)
Stock-based compensation           5,125               5,125
Proceeds from exercise of stock options           7,340               7,340
Proceeds from exercise of stock options (in shares)     1,208,705                      
Vesting of restricted shares     176,610                      
Change in cumulative foreign currency translation adjustment                   2,652       2,652
Ending Balance at Dec. 26, 2020     $ 9     565,815   (171,849)   (29,388)       $ 364,587
Ending Balance (in shares) at Dec. 26, 2020     90,934,930                     90,934,930
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net Loss               (38,332)           $ (38,332)
Stock-based compensation           15,255               15,255
Proceeds from exercise of stock options           2,670               2,670
Proceeds from exercise of stock options (in shares)     435,107                      
Stock Issued During Period, Value, New Issues     $ 4     363,297               363,301
Shares issued to PIPE, net of issuance costs (in shares)     37,500,000                      
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax                   2,517       2,517
Stock Issued During the Period, Value, Warrant Redemption     $ 1     62,414               $ 62,415
Stock Issued During the Period, Shares, Warrant Redemption     6,364,978                     6,364,978
Vesting of restricted shares     88,305                      
Change in cumulative foreign currency translation adjustment                   (283)       $ (283)
Stock Issued During Period, Value, Reverse Recapitalization (in shares)     58,672,000                      
Stock Issued During Period, Value, Reverse Recapitalization     $ 6     377,959               377,965
Ending Balance at Dec. 25, 2021     $ 20     $ 1,387,410   $ (210,181)   $ (27,154)       $ 1,150,095
Ending Balance (in shares) at Dec. 25, 2021     193,995,320                     193,995,320